Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
05/11/2005 | CN1201010C Mass production method of antimicrobial peptide and DNA construct and expression system thereof |
05/11/2005 | CN1201009C Histidine protein-phosphatase |
05/11/2005 | CN1201008C Yeast strains with interrupted ATF2 gene and use |
05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
05/10/2005 | US6891084 For foods/proliferation of Bifidobacterium/drugs for organ preservation solutions; genetic engineering |
05/10/2005 | US6891083 For herbicides/marker systems; genetic engineering; cloning |
05/10/2005 | US6891081 Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof |
05/10/2005 | US6890910 Murd protein and gene of Pseudomonas aeruginosa |
05/10/2005 | US6890908 Modified ribozymes |
05/10/2005 | US6890752 Synthases |
05/10/2005 | US6890748 Production of lysosomal enzymes in plants by transient expression |
05/10/2005 | US6890747 Phosphoinositide 3-kinases |
05/10/2005 | US6890746 Gene participating in the production of homo-glutamic acid and utilization thereof |
05/10/2005 | US6890745 For drug screening enzyme inhibitors/detecting/modulating caspase activity/apoptosis |
05/10/2005 | US6890743 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses |
05/10/2005 | US6890739 Use of uridine diphosphate glucose 4-epimerase |
05/10/2005 | US6890732 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
05/10/2005 | US6890721 For treating Alzheimer's/Parkinson's disease/rheumatoid arthritis/sepsis/stroke/inflammation/ischemia/cardiovascular/ liver disease/multiple sclerosis/acquired immune deficiency syndrome(AIDS)/male pattern baldness/tumors/cancer |
05/10/2005 | US6890572 Bacillus culture product; baked goods |
05/10/2005 | US6890554 Genetic immunization with cationic lipids |
05/10/2005 | US6890539 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections |
05/10/2005 | US6890516 Identifying a substance capable of affecting long term memory in an animal comprising the determination that said substance alters activator homodimer, activator-repressor heterodimer and/ or repressor homodimer formation from normal |
05/10/2005 | CA2118518C Over expression of single-stranded molecules |
05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
05/06/2005 | WO2005040795A2 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepli) |
05/06/2005 | WO2005040428A2 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
05/06/2005 | WO2005040389A2 Compositions with chitinase activity |
05/06/2005 | WO2005040381A1 Rice and products thereof having starch with an increased proportion of amylose |
05/06/2005 | WO2005040372A1 Protease with improved stability in detergents |
05/06/2005 | WO2005040371A1 Engineered enzymes and their use for synthesis of thioglycosides |
05/06/2005 | WO2005040370A2 Thermostable hydrolase |
05/06/2005 | WO2005040369A1 Process for producing penicillin |
05/06/2005 | WO2005040368A2 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
05/06/2005 | WO2005040367A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
05/06/2005 | WO2005040366A1 Trans-2-enoyl-coa reductase gene of euglena gracilis |
05/06/2005 | WO2005040363A1 Glucosyltransferases |
05/06/2005 | WO2005040344A2 Generation of stabilized proteins by combinatorial consensus mutagenesis |
05/06/2005 | WO2005040334A2 Selective lipases and methods of screening therefor |
05/06/2005 | WO2005040207A1 Tyrosine phosphorylation of cdk inhibitor proteins of the cip/kip family |
05/06/2005 | WO2005040197A1 Compositions, methods and kits for biarsenical fluorophore labeling |
05/06/2005 | WO2005040194A2 Methods and compositions for pdgf-c activation and inhibition |
05/06/2005 | WO2005039615A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
05/06/2005 | WO2005039281A1 Genetically modified organisms and uses thereof |
05/06/2005 | WO2005028636A8 Novel cbh1 homologs and variant cbh1 cellulases |
05/06/2005 | WO2005017161A3 Chimeric peptides for the regulation of gtpases |
05/06/2005 | WO2005017116A3 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
05/06/2005 | WO2004113561A3 Methods for diagnosing, monitoring, staging and treating heart failure |
05/06/2005 | WO2004112482A8 Biological active coating components, coatings, and coated surfaces |
05/06/2005 | WO2004111245A3 Gdc-2 genes conferring herbicide resistance |
05/06/2005 | WO2004106508A3 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
05/06/2005 | WO2004099381A3 Genetically modified yeast species and fermentation processes using genetically modified yeast |
05/06/2005 | WO2004098377A3 Methods and compositions for diagnosis and therapy of parkin-associated disorders |
05/06/2005 | WO2004037979A3 Improved sso7-polymerase conjugate proteins |
05/06/2005 | WO2004015096A8 Leech extracts for stents |
05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
05/06/2005 | WO2002072787A3 Telomerase expression repressor proteins and methods of using the same |
05/06/2005 | CA2543789A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
05/06/2005 | CA2543565A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
05/06/2005 | CA2543404A1 Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor |
05/06/2005 | CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
05/06/2005 | CA2541141A1 Trans-2-enoyl-coa reductase gene of euglena gracilis |
05/06/2005 | CA2540810A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
05/05/2005 | US20050097636 OAR polynucleotides, polypeptides and their use in PHA production in plants |
05/05/2005 | US20050097634 Methods of increasing polypeptide accumulation in plants |
05/05/2005 | US20050097632 Phenotype modifying genetic sequences |
05/05/2005 | US20050096273 Regulation of matrix metalloproteinases by PSP94 family members |
05/05/2005 | US20050096256 Compositions for manipulating the lifespan and stress response of cells and organisms |
05/05/2005 | US20050096255 Methods of modulating activity of DXR |
05/05/2005 | US20050095691 Muant acid phosphatase/phytase for use in enhancement nutrient quality and digestibility of animal feeds |
05/05/2005 | US20050095689 Plant protein for use in enhancing ability to absorb insoluble iron in soils and for improving resistance to iron deficiency in plants |
05/05/2005 | US20050095688 Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae |
05/05/2005 | US20050095683 Bacillus serine proteases for use as active agent in cleaning compounds and detergents |
05/05/2005 | US20050095680 Using modified escherichia comprising enhanced carbamoyl-phosphate synthetase activity as a bioreactor for fermentation of arginine for use in medicines, animal feed and cosmetics |
05/05/2005 | US20050095670 Low-substrate-specific racemase for use in producing racemates of various amino acids |
05/05/2005 | US20050095669 Eubacterial rna-polymerase mutants with altered product production |
05/05/2005 | US20050095668 Sepsis shock therapy; anticoagulants; antiinflammatory agents; exhibits an increased resistance towards inactivation by alpha-1-antitrypsin |
05/05/2005 | US20050095625 Membrane-associated guanylate kinase peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis |
05/05/2005 | US20050095619 Enhanced heat resistant glucose dehydrogenase for coupling to oxido- or reductase enzymes to produce synthetic organic chemicals or precursors |
05/05/2005 | US20050095615 Methods and compositions for detecting promoter activity and expressing fusion proteins |
05/05/2005 | US20050095315 Process for the production of alcoholic beverages using maltseed |
05/05/2005 | US20050095248 Use of inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence |
05/04/2005 | EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
05/04/2005 | EP1527191A1 Method for the biotransformation of carotenoids by means of a cytochrome p450 monooxygnase |
05/04/2005 | EP1527189A2 Mutant proteinase inhibitors and uses thereof |
05/04/2005 | EP1527183A2 Novel selection method |
05/04/2005 | EP1527182A2 Process for the production of unsaturated fatty acids |
05/04/2005 | EP1527181A1 Staphylococcal nuclease fusion proteins for the production of recombinant peptides |
05/04/2005 | EP1527170A2 Crystal structure of beta-site app-cleaving enzyme (bace) mutants and uses thereof |
05/04/2005 | EP1527169A2 Leech extracts for stents |
05/04/2005 | EP1527168A1 Saccharose-6-phosphate phosphatase as a target for herbicides |
05/04/2005 | EP1527167A2 Undecaprenyl pyrophosphate synthase (upps) enzyme and methods of use |
05/04/2005 | EP1527166A1 Process for the preparation of l-3,4-dihydroxyphenylalanine by aerobic fermentation of a microorganism |
05/04/2005 | EP1527165A2 A rhodococcus gene encoding aldoxime dehydratase |
05/04/2005 | EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
05/04/2005 | EP1527160A2 Production of glycosylated macrolides in e. coli |
05/04/2005 | EP1527102A1 Proteins and methods useful for assessing risk of cardiovascular disease |
05/04/2005 | EP1506312A4 Metalloprotease peptide substrates and methods |
05/04/2005 | EP1364212A4 Three hybrid assay system |
05/04/2005 | EP1362062B1 Concatameric immunoadhesion |